|
Volumn 40, Issue 1038, 1998, Pages 103-104
|
Thalidomide
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
THALIDOMIDE;
TUMOR NECROSIS FACTOR ALPHA;
ANGIOGENESIS;
APHTHOUS STOMATITIS;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG BLOOD LEVEL;
DRUG MECHANISM;
DRY SKIN;
ERYTHEMA NODOSUM LEPROSUM;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LEPROSY;
ORTHOSTATIC HYPOTENSION;
PERIPHERAL NEUROPATHY;
REVIEW;
TERATOGENICITY;
TREATMENT INDICATION;
XEROSTOMIA;
ABNORMALITIES, DRUG-INDUCED;
ADJUVANTS, IMMUNOLOGIC;
AIDS-RELATED OPPORTUNISTIC INFECTIONS;
ANTI-INFLAMMATORY AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
LEPROSY;
LEPROSY, LEPROMATOUS;
NEOVASCULARIZATION, PHYSIOLOGIC;
STOMATITIS, APHTHOUS;
THALIDOMIDE;
|
EID: 0032561217
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (13)
|